AI assistant
Sending…
DAVITA INC. — Director's Dealing 2016
May 14, 2016
30643_dirs_2016-05-13_8de34505-6d84-4c91-b128-314d0b885953.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-05-12
Reporting Person: Valine Roger (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-12 | Common Stock | M | 18000 | $41.465 | Acquired | 18324 | Direct |
| 2016-05-12 | Common Stock | F | 9780 | $76.32 | Disposed | 8544 | Direct |
| 2016-05-12 | Common Stock | S | 8220 | $76.3423 | Disposed | 324 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-12 | Stock Appreciation Rights | $41.465 | M | 18000 | Disposed | 2016-06-06 | Common Stock (18000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 18104 | Indirect |
Footnotes
F1: Represents the weighted average sale price of $76.3423. The range of prices for the sale of these shares was $76.16-$76.50 rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: The Stock Appreciation Rights were granted on 6/6/2011, and became fully vested on 6/6/2012.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25